Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul;29(7):509-533.
doi: 10.1080/13543776.2019.1629419. Epub 2019 Jun 17.

Carbonic anhydrases as disease markers

Sabina Zamanova  1 , Ahmed M Shabana  1 , Utpal K Mondal  1 , Marc A Ilies  1   2
Affiliations
Review

Carbonic anhydrases as disease markers

Sabina Zamanova et al. Expert Opin Ther Pat. 2019 Jul.

Abstract

Introduction: The physiologic importance of fast CO2/HCO3- interconversion in various tissues requires the presence of carbonic anhydrase (CA, EC 4.2.1.1). Fourteen CA isozymes are present in humans, all of them being used as biomarkers.

Areas covered: A great number of patents and articles were focused on the use of CA isozymes as biomarkers for various diseases and syndromes in the recent years, in an ascending trend over the last decade. The review highlights the most important studies related with each isozyme and covers the most recent patent literature.

Expert opinion: The CAs biomarker research area expanded significantly in recent years, shifting from the predominant use of CA IX and CA XII in cancer diagnostic, staging, and prognosis towards a wider use of CA isozymes as disease biomarkers. CA isozymes are currently used either alone, in tandem with other CA isozymes and/or in combination with other proteins for the detection, staging, and prognosis of a huge repertoire of human dysfunctions and diseases, ranging from mild transformation of the normal tissues to extreme shifts in tissue organization and function. The techniques used for their detection/quantitation and the state-of-the-art in each clinical application are presented through relevant clinical examples and corresponding statistical data.

Keywords: Carbonic anhydrases; biomarker; pathology; physiology.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Figures

Figure 1.
Figure 1.
Cartoon depicting the 14 human CA isozymes, their relative catalytic activity and subcellular localization. For a more detailed overview, see Table 1.
Figure 2.
Figure 2.
CA inhibitors in clinical use, administered either systemically (compounds 1-5, 8, 9) or topically (antiglaucoma compounds 6 and 7, administered directly into the eye). One may notice that all compounds contain a primary sulfonamide/sulfamate group that binds the Zn (II) ion in the active site of CAs.
See this image and copyright information in PMC

References

    1. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discovery. 2008;7:168–181.

      ** Comprehensive review summarizing the therapeutic applications of carbonic anhydrases

    1. Supuran CT. Structure and function of carbonic anhydrases. Biochem J. 2016. July 15;473(14):2023–32. - PubMed

    1. Supuran CT, Capasso C. An Overview of the Bacterial Carbonic Anhydrases. Metabolites. 2017. November 11;7(4).

      * Comprehensive review summarizing the bacterial carbonic anhydrases

    1. Zolfaghari Emameh R, Barker HR, Syrjanen L, et al. Identification and inhibition of carbonic anhydrases from nematodes. J Enzyme Inhib Med Chem. 2016;31(sup4):176–184. - PubMed

    1. Capasso C, Supuran CT. Bacterial, fungal and protozoan carbonic anhydrases as drug targets. Expert Opin Ther Targets. 2015;19(12):1689–704.

      * Important review summarizing structure and applications of bacterial, fungal and protozoan carbonic anhydrases

LinkOut - more resources